Frontiers in Neurology · Nov 2, 2026
Complement dysregulation in perioperative neurocognitive disorders: evidence for peripheral activation, neurovascular barrier dysfunction, and glial synaptic engulfment
By WEN HU, Qing Sun, Jie Chen
Perioperative neurocognitive disorders (PND) encompass cognitive impairment identified before and after anaesthesia and surgery. Complement may connect peripheral inflammation, neurovascular barrier dysfunction, and glial responses to synaptic injury. This narrative review integrates human observations and experimental studies while distinguishing surgery-associated evidence from findings in other models. Rapid circulating complement activation is well documented during cardiopulmonary bypass, but its magnitude and relation to cognitive outcomes after other procedures remain less certain. One aged-mouse surgical study identifies increased hepatic C3 supply and entry into the hippocampus; local astrocytic or myeloid C3 and microglial C1q provide additional potential sources. Surgical-model interventions implicate C3a–C3aR signalling in neurovascular inflammation and glial activation, and C1q or C3 reduction can attenuate synaptic engulfment. However, the complete C1q–C3b/iC3b–CR3 pathway is unconfirmed in PND, and engulfment does not establish selective removal of otherwise viable synapses. Small human studies associate complement-related proteins, transcripts, extracellular-vesicle cargo, and exploratory CSF C3a measures with postoperative outcomes, without establishing clinically useful prediction or central causality. Complement also supports host defence, debris clearance, and tissue recovery, making the effects of inhibition dependent on target, compartment, and timing. Current evidence supports complement as one contributor within a multifactorial process involving inflammatory, neurotransmitter, and metabolic mechanisms. Larger phenotype-specific human studies and cell-selective, appropriately timed experimental interventions are needed to establish therapeutic value.